To include your compound in the COVID-19 Resource Center, submit it here.

Alder falls after CEO Schatzman departs

Alder BioPharmaceuticals Inc. (NASDAQ:ALDR) fell $2.05 (15%) to $11.55 on Wednesday after President and CEO Randall

Read the full 160 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE